Genesis Therapeutics is an innovative biotechnology company engaging its proprietary molecular AI technology to transform clinical outcomes for patients. The company was founded in 2019 out of Stanford University by Evan Feinberg Ph.D., co-founded by Ben Sklaroff, and backed by Vijay Pande, Ph.D. In addition, Peppi Prasit, Ph.D. leads the Scientific Advisory Board and Leonard Bell, M.D., serves as Chair of the Board of Directors. Its team of technology trailblazers and proven drug developers are driving the discovery and development of novel small molecule drugs to treat patients suffering with severe and debilitating diseases. The company expects to develop drug candidates both internally and selectively in partnership with biopharmaceutical companies. 

Biotechnology

Education

Genesis Therapeutics

Evan Feinberg

Mabel Zhao

Bing Han

Wang Xu

Luis Landgrave

Karin Zeh

Louie Naumovski

Indrawan McAlpine

Ben Sklaroff

Matt Pan

Parvin Parineh

Peppi Prasit

Will McCarthy

The leadership team at Genesis Therapeutics has a lot of experience in the industry, having worked with companies such as Bina Technologies, Roche, Genentech, and Dropbox. They also have a lot of education between them, with degrees from universities such as the University of Pennsylvania.

Leadership Team

CEO and Executive Team

Board of Directors

Leadership Team

About

Team members

Other teams at Genesis Therapeutics

CEO and Executive Team

Board of Directors